V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014911 | 270010724 | 1.83 | 68.6 | Palliative (P) | 2014-09-04 | 2014-09-04 | CARBOPLATIN + CETUXIMAB + FU | N | N | 270025740 | BEVACIZUMAB + CAPECITABINE |
| 270014912 | 270010725 | null | 67.4 | Disease modification (D) | null | 2017-04-18 | CARBOPLATIN + RT | N | N | 270025795 | BEVACIZUMAB + CAPECITABINE |
| 270014913 | 270015009 | 1.69 | 67 | Adjuvant (A) | 2015-10-15 | 2015-10-22 | FLUOROURACIL + RT | N | N | 270025795 | SCOT TRIAL |
| 270014914 | 270015009 | 1.73 | null | Palliative (P) | 2014-05-10 | 2014-05-31 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 270025795 | CARBO + FLUOROURACIL |
| 270014915 | 270015009 | 1.71 | null | Disease modification (D) | 2015-09-13 | 2015-09-27 | Carboplatin + Cetux + FU (>Cycle 2) | null | N | 270025795 | BEVACIZUMAB + CAPECITABINE |
| 270014916 | 270010727 | null | 82.4 | Curative (C) | null | 2015-02-14 | CARBOPLATIN + RT | null | null | 270025840 | CAP + RT |
| 270014917 | 270010728 | 1.62 | 52.6 | Palliative (P) | 2015-04-28 | 2015-05-02 | Bevacizumab + Irinotecan + MdG | 02 | null | 270025842 | CETUXIMAB + CISPLATIN + FU |
| 270014918 | 270010729 | 1.59 | null | Curative (C) | 2016-11-10 | 2016-11-26 | ECHELON 1 TRIAL | 99 | null | 270025857 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270014919 | 270010731 | 1.78 | 67 | Palliative (P) | 2018-02-23 | 2018-02-23 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | N | N | 270025859 | IMATINIB |
| 270014920 | 270010733 | 1.96 | 69.5 | Curative (C) | 2013-12-14 | 2013-12-19 | IBRUTINIB | N | N | 270025862 | PEMBROLIZUMAB |
| 270014921 | 270010733 | 1.6 | null | Curative (C) | 2017-07-21 | 2017-07-22 | Paclitaxel 7 day | 02 | N | 270025862 | DOCETAXEL |
| 270014922 | 270010736 | 1.7 | 74 | Disease modification (D) | 2017-02-26 | 2017-03-21 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 270025878 | CARBO + FLUOROURACIL |
| 270014923 | 270010739 | 1.71 | 90.4 | null | 2017-05-09 | 2017-05-09 | IRINOTECAN + MDG + PANITUMUMAB | 2 | N | 270000307 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014924 | 270015015 | 1.75 | 60 | Palliative (P) | 2013-06-13 | 2013-06-13 | Docetaxel | 02 | N | 270000361 | DOCETAXEL |
| 270014925 | 270010742 | 1.8 | 66.1 | Palliative (P) | 2017-05-12 | 2017-05-17 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 270000403 | CISPLATIN + FLUOROURACIL + RT |
| 270014926 | 270010743 | null | 100 | Curative (C) | 2015-10-20 | 2016-02-18 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 270000882 | METHOTREXATE HIGH DOSE |
| 270014927 | 270010745 | 1.6 | 44.4 | Palliative (P) | null | 2018-08-26 | CETUXIMAB + OXALIPLATIN | N | N | 270001072 | DA |
| 270014928 | 270010746 | 1.64 | 92.3 | Curative (C) | 2018-03-06 | 2018-05-12 | CARBOPLATIN + CETUXIMAB + FU | N | Y | 270001351 | EPOC TRIAL |
| 270014929 | 270010750 | 1.87 | 31 | Curative (C) | 2016-08-25 | 2016-08-25 | Pemetrexed | N | N | 270001661 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014930 | 270015016 | 1.71 | 67 | Curative (C) | 2017-09-21 | 2017-10-07 | Capital Trial | 01 | N | 270002085 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 270014931 | 270015016 | 1.74 | 78.75 | Curative (C) | 2016-08-28 | 2016-09-09 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | 270002085 | CETUXIMAB + IRINOTECAN |
| 270014932 | 270010752 | 1.74 | 93.1 | Curative (C) | 2017-10-13 | 2017-10-14 | CAPECITABINE + CETUXIMAB + IRINOTECAN | 02 | N | 270002417 | PEMETREXED |
| 270014933 | 270010753 | 1.7 | 85 | Curative (C) | 2018-04-12 | 2018-05-08 | Cisplatin + Docetaxel +Fluorouracil | N | N | 270002435 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014934 | 270015017 | 1.59 | 48.7 | Curative (C) | 2016-11-15 | 2016-11-15 | Bevacizumab + FLUOROURACIL + IRINOTECAN | N | N | 270002435 | DOCETAXEL |
| 270014935 | 270015018 | null | null | Palliative (P) | 2015-11-29 | 2015-12-06 | Carboplatin + Etoposide IV 3 day | null | N | 270002563 | DOXORUBICIN |
| 270014936 | 270010755 | 1.64 | 56.6 | Palliative (P) | 2014-04-18 | 2014-04-18 | Cisplatin + Vinorelbine (IV) | 01 | N | 270002807 | CARBOPLATIN + RT |
| 270014937 | 270010757 | 1.58 | 50 | null | 2018-05-22 | 2018-07-04 | CARBOPLATIN + RT | Y | null | 270003440 | DA |
| 270014938 | 270010758 | 152 | 75.5 | Curative (C) | 2017-02-22 | 2017-03-05 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 270003570 | DOCETAXEL |
| 270014939 | 270010759 | 1.74 | 77.3 | Disease modification (D) | 2016-06-12 | 2016-06-16 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 270003575 | CARBOPLATIN + CETUXIMAB + FU |
| 270014940 | 270010760 | 1.8 | 59 | null | 2017-05-04 | 2017-05-05 | Capecitabine + Mitomycin | N | null | 270003718 | CISPLATIN + VINORELBINE |
| 270014941 | 270010763 | 1.73 | 72 | Palliative (P) | 2018-12-26 | 2018-12-26 | Carboplatin + Cetux + FU (Cycle 1) | 02 | N | 270003817 | DOCETAXEL |
| 270014942 | 270010764 | 1.7 | 108 | Curative (C) | 2018-04-29 | 2018-04-29 | Abiraterone | 02 | N | 270004101 | FEC |
| 270014943 | 270010766 | 0 | 90.3 | Adjuvant (A) | 2017-04-15 | 2017-04-17 | CARBOPLATIN + RT | N | N | 270004101 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014944 | 270010767 | null | null | Curative (C) | null | 2017-03-07 | Cisplatin + Pemetrexed | null | null | 270004490 | CARBOPLATIN + CETUXIMAB + FU |
| 270014945 | 270010769 | 1.61 | 59.4 | Curative (C) | 2015-09-16 | 2015-09-20 | Docetaxel 75mg/m2 (21 day) | N | N | 270004490 | GEMCARBO |
| 270014946 | 270010769 | 1.71 | 81 | T | 2014-05-21 | 2014-06-06 | SCOT TRIAL | Y | N | 270004490 | TRASTUZUMAB |
| 270014947 | 270010770 | 1.83 | null | Disease modification (D) | 2015-06-28 | 2015-07-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270004767 | CAPECITABINE + CARBOPLATIN |
| 270014948 | 270015022 | 1.75 | null | null | null | 2018-01-02 | CARBOPLATIN + RT | null | N | 270004836 | CARBOPLATIN + RT |
| 270014949 | 270010775 | 1.63 | 74.9 | Palliative (P) | 2019-04-29 | 2019-04-30 | IBRUTINIB | 02 | N | 270004873 | BEVACIZUMAB + IRINOTECAN + MdG |
| 270014950 | 270010776 | 185 | 59 | Palliative (P) | 2018-07-29 | 2018-07-29 | AXITINIB | N | null | 270004923 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 270014951 | 270015025 | null | 84 | Palliative (P) | 2017-02-18 | 2017-02-20 | Carbo F | N | N | 270004960 | CARBOPLATIN + CETUXIMAB + FU |
| 270014952 | 270015025 | 1.71 | 60.9 | Palliative (P) | null | 2016-10-12 | CAPECITABINE + CETUXIMAB + IRINOTECAN | 02 | N | 270004960 | PACLITAXEL |
| 270014953 | 270015025 | 1.73 | 59.5 | Palliative (P) | 2013-12-22 | 2013-12-25 | Capital Trial | N | Y | 270004960 | DABRAFENIB |
| 270014954 | 270015026 | null | null | Curative (C) | 2017-06-14 | 2017-06-28 | Bevacizumab + Capecitabine | 02 | N | 270005145 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270014955 | 270010780 | 1.58 | -1 | Curative (C) | null | 2017-10-01 | Lenalidomide 25mg (Cycle 1 to 25) | null | null | 270005171 | CETUXIMAB + MDG |
| 270014956 | 270017292 | 1.76 | 73.45 | Palliative (P) | 2018-05-20 | 2018-06-14 | CARBOPLATIN + RT | 02 | N | 270005171 | CARBOPLATIN + RT |
| 270014957 | 270017292 | null | null | null | 2016-07-29 | 2016-08-18 | CARBOPLATIN + RT | 2 | N | 270005171 | CARBOPLATIN + RT |
| 270014958 | 270017292 | 1.69 | 76 | Not known (9) | 2018-06-24 | 2018-07-03 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 270005171 | DOCETAXEL |
| 270014959 | 270010782 | 1.58 | 61.8 | Palliative (P) | 2017-01-23 | 2017-01-30 | Carboplatin + Etoposide IV 3 day | 02 | N | 270005520 | CARBOPLATIN + CETUXIMAB + FU |
| 270014960 | 270015028 | 1.76 | 92.2 | Palliative (P) | 2018-03-10 | 2018-04-22 | Ralitrexed | N | Y | 270005602 | IBRUTINIB |